Natco And MSN Battle Chugai Over Alectinib In India
Originator Pursues Alecensa Patent Infringement Charges In Delhi High Court
Executive Summary
Roche affiliate Chugai has moved court in India seeking to restrain Natco and MSN Laboratories over alleged infringement of its patent concerning Alecensa. The Indian firms, however, contend their actions fall under the ambit of the country’s “Bolar exemption” provision.